AI for pharmaceutical manufacturing
AI for pharmaceutical manufacturing
Help manufacturing and quality teams review records, find evidence and investigate recurring problems. NeoBram provides pharmaceutical manufacturing AI consulting and engineering around a defined workflow, with your specialists owning intended use, quality decisions and acceptance.
A practical first scope
Start with one intended assistance task, such as gathering deviation evidence or checking record completeness.
- Possible output: a permitted-source map, source-linked review workflow and evaluation findings for the agreed records.
- Your contribution: quality and validation owners, approved representative records, access requirements and accepted historical examples.
- Quality and value: check missing or unsupported evidence and the effort to correct it before counting time released. Authorized people retain investigation, CAPA and batch decisions.
- Next decision: review intended use, evidence gaps and validation needs before authorizing further work.
Begin with one controlled manufacturing workflow
Choose a task with a clear owner, available evidence and a useful outcome: checking record completeness, locating investigation evidence or retrieving the current approved procedure. We examine where staff spend time, what information is permitted and what the application should do when records are missing or uncertain.
You do not need an internal AI team. Your quality, validation, IT and process specialists contribute domain knowledge and requirements; NeoBram supplies data engineering, software development, integration and technical evaluation.
Prepare a reviewable record reconciliation
An illustrative reconciliation task compares selected entries in a batch record with the corresponding equipment log and approved source information. The application presents candidate discrepancies with the relevant pages and values side by side. Reviewers can confirm the issue, correct extraction or explain an acceptable difference. This gives the quality team a focused queue while preserving the underlying records and the reasoning for each resolution.
- Define the fields, record versions and comparison rules within the intended use
- Include handwriting, unreadable scans, missing pages and changed layouts in the test set
- Retain source references, reviewer corrections and unresolved items in the agreed output
Support batch record review before QA release
AI-assisted batch manufacturing record review can extract selected fields, compare entries with an approved master and flag defined completeness or calculation exceptions. Scanned paper records require checks for readability, transcription errors and changed layouts. Every flag should lead a reviewer back to the source.
Measure the time released after QA checking and correction, alongside missed exceptions and unnecessary flags. Your quality team approves how the assistance fits the review process. Batch disposition and release remain with authorised personnel under your procedures; changes in rejected-batch costs need separate evidence.
Bring evidence into deviation investigations and CAPA review
Investigation support assembles relevant batch, laboratory, equipment and procedure records, proposes a checkable chronology and retrieves comparable deviations. Similarity is a reason to investigate, not proof of root cause. Conflicting evidence and gaps must remain visible.
An assistant can organise supporting material for a CAPA draft and effectiveness review. Investigators approve conclusions, actions and closure. Our anonymised pharma case describes source-linked evidence assistance; its non-public underlying records and measurement limits do not establish compliance or predict another facility’s outcome.
Retrieve approved SOPs with checkable sources
A controlled knowledge assistant can search a permitted document collection and show the document, effective version and passage behind an answer. Access, product and site scope matter. We test obsolete versions, unavailable sources, conflicting instructions and questions the collection cannot answer.
Document owners retain approval responsibility. The application needs a defined update process so newly effective procedures and withdrawn records are handled deliberately.
Assess inspection, process variation and supply planning separately
Visual inspection needs representative images and explicit defect criteria. Process analytics needs batch, material, equipment and quality context to identify patterns worth investigating. Supply-planning support can examine demand, inventory and material availability against the planner’s existing baseline.
Each has a different data requirement, acceptance test and operating owner. A successful document assistant is not evidence of predictive-quality performance, and a batch-rejection estimate does not measure record-review productivity.
Build evidence your reviewers can evaluate
Together we turn known exceptions and unacceptable behaviours into test cases. Evaluation covers source selection, extraction, answer quality, permissions and reviewer corrections. Your responsible teams determine the applicable validation and change-control requirements. NeoBram’s technical documentation and testing deliverables are agreed against that scope.
Agree deployment and ongoing responsibilities
Private, on-premises and offline options depend on selected components, model licences and hardware. We document data movement, dependencies and update routes. Deployment location alone does not establish compliance. The engagement defines training, support, controlled updates and day-to-day ownership before handover.
Make review effort and quality visible
The engineering scope can include a field-and-source map, exception categories, representative test cases and a technical results record for your responsible teams to review. Compare the complete assisted task with the existing method, including checking and correction. Report consequential missed exceptions separately from minor extraction errors. Your quality and validation owners determine how the evidence fits the approved process and what must be repeated when records or software change.
- Measure preparation and QA review time without treating faster review as release approval
- Track false flags, missed exceptions and the effort needed to resolve each category
- Separate review capacity released from any independently evidenced reduction in batch losses
Review a pharmaceutical manufacturing workflow
Bring a recurring task, its accountable owner and the records already used to perform it. We will help define a practical starting scope.
More clarity
Questions and answers
Which pharma AI project should we start with?
Choose a bounded task with accessible records and a named owner. Batch-record checks, approved-document retrieval and evidence assembly can be evaluated against specific review requirements.
Can AI approve a batch or close a deviation?
No. Release, investigation closure and other consequential quality approvals remain with authorised people and approved procedures.
Can the assistant use only approved documents?
It can be designed around a controlled collection and permissions. Testing must include version selection, unavailable sources and questions the collection cannot answer.
Is the delivered system automatically validated?
No. Intended use, risk and your quality system determine the required activities and approvals. NeoBram agrees its engineering and evidence deliverables with your responsible teams.
Can pharma manufacturing AI run on premises?
On-premises or offline operation can be assessed for the selected workload, licences and infrastructure. Access, maintenance and update requirements still need explicit design.
Can the first evaluation use anonymised or representative records?
Yes, provided they preserve the layouts, variation and exception types needed for the test. Document differences from actual records. A later evaluation may still need approved representative operational material before routine use is considered.
What happens when the AI and the reviewer disagree?
Keep the source evidence available and let the authorised reviewer resolve the item under the applicable procedure. Record the correction and reason where appropriate, then use recurring disagreements to improve testing and clarify the system's permitted role.
Start with one business problem
